Company Filing History:
2 out of 177 
2 out of 77 
Years Active: 2018-2019
Title: Ah-Young Oh: Innovator in Cancer Treatment
Introduction
Ah-Young Oh is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents to his name, his work focuses on developing compounds that can inhibit specific protein interactions related to cancer.
Latest Patents
Ah-Young Oh's latest patents include a compound for inhibiting the binding between DX2 protein and p14/ARF protein. This compound is part of a pharmaceutical composition aimed at treating or preventing cancer diseases. The invention also includes an anticancer adjuvant designed to enhance the effectiveness of drug-resistant anticancer drugs. Additionally, it features a composition that includes an AIMP2-DX2 protein or a fragment thereof, which can be utilized for diagnosing lung cancer.
Career Highlights
Throughout his career, Ah-Young Oh has worked at notable institutions such as Pusan National University and the Industry & Academic Cooperation in Chungnam National University. His research has been pivotal in advancing the understanding of cancer treatment options.
Collaborations
Ah-Young Oh has collaborated with esteemed colleagues, including Bum Joon Park and Gyu Yong Song. Their combined efforts have contributed to the development of innovative solutions in cancer research.
Conclusion
Ah-Young Oh's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents reflect a commitment to improving therapeutic options for patients facing cancer.